Dr. Marilena Melas has been an Assistant Director in Molecular Diagnostics (Oncology) at the New York Genome Center since August of 2021. She holds an integrated BS-MSc in applied biology and biotechnology from the University of Ioannina in Greece and two master’s degrees (in molecular medicine from the University of Crete, Greece, and in genetics of human diseases from University College, London, UK. Dr. Melas completed her PhD in cancer biology and genomics at the USC Norris Comprehensive Cancer Center/University of Southern California Keck School of Medicine in Los Angeles. Dr. Melas completed an ABMGG clinical laboratory genetics and genomics (LGG) fellowship at the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital, which is affiliated with Ohio State University. In her current role as a laboratory geneticist, Dr. Melas specializes in cancer genome diagnostics, focusing on the analysis, evaluation, interpretation, and reporting of clinical molecular test results for oncology genome and transcriptome sequencing assays. She currently serves as a junior member of the Board of Directors of the Cancer Genomics Consortium (CGC) and volunteers as a Communications Committee and Program Committee member at CGC. Her research interests broadly include the translation of genomic discoveries into clinical and therapeutic applications in the field of personalized medicine in order to provide high-quality and state-of-the-art patient care.